Neuronostics

Enhancing neurological care using digital biomarkers.

At Neuronostics, we are reimagining how neurological conditions, such as epilepsy, are diagnosed and treated.

A multi-award-winning start-up based in Bristol, our powerful digital biomarkers interrogate routinely acquired brain data (EEG) and reveal features that are otherwise hidden to current clinical analysis. Rather than focussing on the visual identification of markers in the EEG that indicate seizures, BioEP is built upon a set of properties of the brain that, when in its resting state, are known to be altered in people with epilepsy.

Currently raising funds via SETsquared Partnership.

Healthcare Medtech

Website

Filings

Financials

Raising:	£7,500,000
Deadline:	18-09-2025

Learn More

The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.

We act as an investment opportunity aggregator, collecting hundreds of investment opportunities from across the UK.

If you'd like your events, opportunities and news listed here please join free as an organisation.